Global Prostaglandin Market is valued approximately USD 461.30 million in 2018 and is anticipated to grow with a healthy growth rate of more than 4.84% over the forecast period 2019-2026. Prostaglandins are autocank derived from arachidonic acid. They both sustain homeostatic functions and mediate pathogenic mechanisms, including the inflammatory response. Prostaglandins control several processes in the body, especially as it relates to the healing process. When tissue is damaged or infected, this group of hormones will create the reactions that cause pain, fever and inflammation, which sparks the healing process. Prostaglandins also stimulate the formation of a blood clot and the contraction of the blood vessel wall when body is bleeding. Once blood clots are no longer needed and the injury begins to heal, another prostaglandin will stimulate the changes that allow the clots to dissipate and the blood vessel wall to relax. Increasing incidences of digestive problem and rising prevalence of cardiovascular diseases are the factors that contributing towards growth of global Prostaglandin market. Further, prostaglandins help in increasing concentration of cAMP, calcium ions and activate G proteins inside the cells, all of which are involved in the transfer of energy and inflammatory signaling process which is the factor that regulates their demand across various regions. However, high cost of treatment and several side-effects associated with its over-dose such as migraines and decrease the ability to fight with cancer are the factors that anticipated to restrain the market growth during the forecast period. The regional analysis of global Prostaglandin market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World.
Major market player included in this report are:
CEPIA
Johnson Matthey
Pfizer
Cayman Chemical
EMD Millipore
Yonsung Fine Chemicals
Everlight Chemical
Piramal Enterprises
Bio-Techne Corporation
Mironova Labs
Chirogate
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Type:
Human Prostaglandin
Veterinary Prostaglandin
By Application:
Cardiovascular
Digestive
Gynecological & Obstetrical
Ophthalmologic
Others
By Regions:
North America
U.S.
Canada
Europe
UK
Germany
Asia Pacific
China
India
Japan
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2016, 2017
Base year – 2018
Forecast period – 2019 to 2026
Target Audience of the Global Prostaglandin Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
Interested in this report?
Get your sample now!
TABLE OF CONTENTS
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Key Trends
1.3. Global & Segmental Market Estimates & Forecasts, 2016-2026 (USD Million)
1.3.1. Prostaglandin Market, by Type, 2016-2026 (USD Million)
1.3.2. Prostaglandin Market, by Application, 2016-2026 (USD Million)
1.3.3. Prostaglandin Market, by Region, 2016-2026 (USD Million)
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Prostaglandin Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Prostaglandin Market Dynamics
3.1. See Saw Analysis
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Global Prostaglandin Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Buyers
4.1.2. Bargaining Power of Suppliers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model
4.2. PEST Analysis
4.2.1. Political Scenario
4.2.2. Economic Scenario
4.2.3. Social Scenario
4.2.4. Technological Scenario
4.3. Key Buying Criteria (On Demand)
4.4. Regulatory Framework (On Demand)
4.5. Investment Vs Adoption Scenario (On Demand)
4.6. Analyst Recommendation & Conclusion
Chapter 5. Global Prostaglandin Market, by Type
5.1. Market Snapshot
5.2. Market Performance - Potential Model
5.3. Prostaglandin Market, Sub Segment Analysis
5.3.1. Human Prostaglandin
5.3.1.1. Market estimates & forecasts, 2016-2026 (USD Million)
5.3.1.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Million)
5.3.2. Veterinary Prostaglandin
5.3.2.1. Market estimates & forecasts, 2016-2026 (USD Million)
5.3.2.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Million)
Chapter 6. Global Prostaglandin Market, by Application
6.1. Market Snapshot
6.2. Market Performance - Potential Model
6.3. Prostaglandin Market, Sub Segment Analysis
6.3.1. Cardiovascular
6.3.1.1. Market estimates & forecasts, 2016-2026 (USD Million)
6.3.1.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Million)
6.3.2. Digestive
6.3.2.1. Market estimates & forecasts, 2016-2026 (USD Million)
6.3.2.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Million)
6.3.3. Gynecological & Obstetrical
6.3.3.1. Market estimates & forecasts, 2016-2026 (USD Million)
6.3.3.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Million)
6.3.4. Ophthalmologic
6.3.4.1. Market estimates & forecasts, 2016-2026 (USD Million)
6.3.4.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Million)
6.3.5. Others
6.3.5.1. Market estimates & forecasts, 2016-2026 (USD Million)
6.3.5.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Million)
Chapter 7. Global Prostaglandin Market, by Regional Analysis
7.1. Prostaglandin Market, Regional Market Snapshot (2016-2026)
7.2. North America Prostaglandin Market Snapshot
7.2.1. U.S.
7.2.1.1. Market estimates & forecasts, 2016-2026 (USD Million)
7.2.1.2. Type breakdown estimates & forecasts, 2016-2026 (USD Million)
7.2.1.3. Application breakdown estimates & forecasts, 2016-2026 (USD Million)
7.2.2. Canada
7.2.2.1. Market estimates & forecasts, 2016-2026 (USD Million)
7.2.2.2. Type breakdown estimates & forecasts, 2016-2026 (USD Million)
7.2.2.3. Application breakdown estimates & forecasts, 2016-2026 (USD Million)
7.3. Europe Prostaglandin Market Snapshot
7.3.1. U.K.
7.3.1.1. Market estimates & forecasts, 2016-2026 (USD Million)
7.3.1.2. Type breakdown estimates & forecasts, 2016-2026 (USD Million)
7.3.1.3. Application breakdown estimates & forecasts, 2016-2026 (USD Million)
7.3.2. Germany
7.3.2.1. Market estimates & forecasts, 2016-2026 (USD Million)
7.3.2.2. Type breakdown estimates & forecasts, 2016-2026 (USD Million)
7.3.2.3. Application breakdown estimates & forecasts, 2016-2026 (USD Million)
7.3.3. Rest of Europe
7.3.3.1. Market estimates & forecasts, 2016-2026 (USD Million)
7.3.3.2. Type breakdown estimates & forecasts, 2016-2026 (USD Million)
7.3.3.3. Application breakdown estimates & forecasts, 2016-2026 (USD Million)
7.4. Asia Prostaglandin Market Snapshot
7.4.1. China
7.4.1.1. Market estimates & forecasts, 2016-2026 (USD Million)
7.4.1.2. Type breakdown estimates & forecasts, 2016-2026 (USD Million)
7.4.1.3. Application breakdown estimates & forecasts, 2016-2026 (USD Million)
7.4.2. India
7.4.2.1. Market estimates & forecasts, 2016-2026 (USD Million)
7.4.2.2. Type breakdown estimates & forecasts, 2016-2026 (USD Million)
7.4.2.3. Application breakdown estimates & forecasts, 2016-2026 (USD Million)
7.4.3. Japan
7.4.3.1. Market estimates & forecasts, 2016-2026 (USD Million)
7.4.3.2. Type breakdown estimates & forecasts, 2016-2026 (USD Million)
7.4.3.3. Application breakdown estimates & forecasts, 2016-2026 (USD Million)
7.4.4. Rest of Asia Pacific
7.4.4.1. Market estimates & forecasts, 2016-2026 (USD Million)
7.4.4.2. Type breakdown estimates & forecasts, 2016-2026 (USD Million)
7.4.4.3. Application breakdown estimates & forecasts, 2016-2026 (USD Million)
7.5. Latin America Prostaglandin Market Snapshot
7.5.1. Brazil
7.5.1.1. Market estimates & forecasts, 2016-2026 (USD Million)
7.5.1.2. Type breakdown estimates & forecasts, 2016-2026 (USD Million)
7.5.1.3. Application breakdown estimates & forecasts, 2016-2026 (USD Million)
7.5.2. Mexico
7.5.2.1. Market estimates & forecasts, 2016-2026 (USD Million)
7.5.2.2. Type breakdown estimates & forecasts, 2016-2026 (USD Million)
7.5.2.3. Application breakdown estimates & forecasts, 2016-2026 (USD Million)
7.6. Rest of The World
7.6.1. South America
7.6.1.1. Market estimates & forecasts, 2016-2026 (USD Million)
7.6.1.2. Type breakdown estimates & forecasts, 2016-2026 (USD Million)
7.6.1.3. Application breakdown estimates & forecasts, 2016-2026 (USD Million)
7.6.2. Middle East and Africa
7.6.2.1. Market estimates & forecasts, 2016-2026 (USD Million)
7.6.2.2. Type breakdown estimates & forecasts, 2016-2026 (USD Million)
7.6.2.3. Application breakdown estimates & forecasts, 2016-2026 (USD Million)
Chapter 8. Competitive Intelligence
8.1. Company Market Share (Subject to Data Availability)
8.2. Top Market Strategies
8.3. Company Profiles
8.3.1. CEPIA
8.3.1.1. Overview
8.3.1.2. Financial (Subject to Data Availability)
8.3.1.3. Product Summary
8.3.1.4. Recent Developments
8.3.2. Johnson Matthey
8.3.3. Pfizer
8.3.4. Cayman Chemical
8.3.5. EMD Millipore
8.3.6. Yonsung Fine Chemicals
8.3.7. Everlight Chemical
8.3.8. Piramal Enterprises
8.3.9. Bio-Techne Corporation
8.3.10. Mironova Labs
8.3.11. Chirogate
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.1.6. Research Assumption
List of Tables
TABLE 1. LIST OF SECONDARY SOURCES, USED IN THE STUDY OF PROSTAGLANDIN MARKET
TABLE 2. LIST OF PRIMARY SOURCES, USED IN THE STUDY OF PROSTAGLANDIN MARKET
TABLE 3. PROSTAGLANDIN MARKET, REPORT SCOPE
TABLE 4. YEARS CONSIDERED FOR THE STUDY
TABLE 5. EXCHANGE RATES CONSIDERED
TABLE 6. PROSTAGLANDIN MARKET ESTIMATES & FORECASTS BY REGION 2016-2026 (USD MILLION)
TABLE 7. PROSTAGLANDIN MARKET ESTIMATES & FORECASTS BY TYPE 2016-2026 (USD MILLION)
TABLE 8. PROSTAGLANDIN MARKET ESTIMATES & FORECASTS BY APPLICATION 2016-2026 (USD MILLION)
TABLE 9. PROSTAGLANDIN MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 10. PROSTAGLANDIN MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 11. PROSTAGLANDIN MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 12. PROSTAGLANDIN MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 13. PROSTAGLANDIN MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 14. PROSTAGLANDIN MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 15. PROSTAGLANDIN MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 16. PROSTAGLANDIN MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 17. PROSTAGLANDIN MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 18. PROSTAGLANDIN MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 19. PROSTAGLANDIN MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 20. PROSTAGLANDIN MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 21. PROSTAGLANDIN MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 22. PROSTAGLANDIN MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 23. PROSTAGLANDIN MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 24. PROSTAGLANDIN MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 25. PROSTAGLANDIN MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 26. PROSTAGLANDIN MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 27. PROSTAGLANDIN MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 28. PROSTAGLANDIN MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 29. PROSTAGLANDIN MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 30. PROSTAGLANDIN MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 31. PROSTAGLANDIN MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 32. PROSTAGLANDIN MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 33. PROSTAGLANDIN MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 34. PROSTAGLANDIN MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 35. PROSTAGLANDIN MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 36. PROSTAGLANDIN MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 37. PROSTAGLANDIN MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 38. PROSTAGLANDIN MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 39. PROSTAGLANDIN MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 40. PROSTAGLANDIN MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 41. PROSTAGLANDIN MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 42. PROSTAGLANDIN MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 43. PROSTAGLANDIN MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 44. PROSTAGLANDIN MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 45. U.S. PROSTAGLANDIN MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 46. U.S. PROSTAGLANDIN MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 47. U.S. PROSTAGLANDIN MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 48. U.S. PROSTAGLANDIN MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 49. U.S. PROSTAGLANDIN MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 50. CANADA PROSTAGLANDIN MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 51. CANADA PROSTAGLANDIN MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 52. CANADA PROSTAGLANDIN MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 53. CANADA PROSTAGLANDIN MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 54. CANADA PROSTAGLANDIN MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 55. UK PROSTAGLANDIN MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 56. UK PROSTAGLANDIN MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 57. UK PROSTAGLANDIN MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 58. UK PROSTAGLANDIN MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 59. UK PROSTAGLANDIN MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 60. GERMANY PROSTAGLANDIN MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 61. GERMANY PROSTAGLANDIN MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 62. GERMANY PROSTAGLANDIN MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 63. GERMANY PROSTAGLANDIN MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 64. GERMANY PROSTAGLANDIN MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 65. ROE PROSTAGLANDIN MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 66. ROE PROSTAGLANDIN MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 67. ROE PROSTAGLANDIN MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 68. ROE PROSTAGLANDIN MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 69. ROE PROSTAGLANDIN MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 70. CHINA PROSTAGLANDIN MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 71. CHINA PROSTAGLANDIN MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 72. CHINA PROSTAGLANDIN MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 73. CHINA PROSTAGLANDIN MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 74. CHINA PROSTAGLANDIN MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 75. INDIA PROSTAGLANDIN MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 76. INDIA PROSTAGLANDIN MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 77. INDIA PROSTAGLANDIN MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 78. INDIA PROSTAGLANDIN MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 79. INDIA PROSTAGLANDIN MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 80. JAPAN PROSTAGLANDIN MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 81. JAPAN PROSTAGLANDIN MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 82. JAPAN PROSTAGLANDIN MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 83. JAPAN PROSTAGLANDIN MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 84. JAPAN PROSTAGLANDIN MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 85. ROAPAC PROSTAGLANDIN MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 86. ROAPAC PROSTAGLANDIN MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 87. ROAPAC PROSTAGLANDIN MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 88. ROAPAC PROSTAGLANDIN MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 89. ROAPAC PROSTAGLANDIN MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 90. BRAZIL PROSTAGLANDIN MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 91. BRAZIL PROSTAGLANDIN MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 92. BRAZIL PROSTAGLANDIN MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 93. BRAZIL PROSTAGLANDIN MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 94. BRAZIL PROSTAGLANDIN MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 95. MEXICO PROSTAGLANDIN MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 96. MEXICO PROSTAGLANDIN MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 97. MEXICO PROSTAGLANDIN MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 98. MEXICO PROSTAGLANDIN MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 99. MEXICO PROSTAGLANDIN MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 100. ROLA PROSTAGLANDIN MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 101. ROLA PROSTAGLANDIN MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 102. ROLA PROSTAGLANDIN MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 103. ROLA PROSTAGLANDIN MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 104. ROLA PROSTAGLANDIN MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 105. ROW PROSTAGLANDIN MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 106. ROW PROSTAGLANDIN MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 107. ROW PROSTAGLANDIN MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 108. ROW PROSTAGLANDIN MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 109. ROW PROSTAGLANDIN MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
List of Figures
FIG 1. PROSTAGLANDIN MARKET, RESEARCH METHODOLOGY
FIG 2. PROSTAGLANDIN MARKET, MARKET ESTIMATION TECHNIQUES
FIG 3. GLOBAL MARKET SIZE ESTIMATES & FORECAST METHODS
FIG 4. PROSTAGLANDIN MARKET, KEY TRENDS 2017
FIG 5. PROSTAGLANDIN MARKET, GROWTH PROSPECTS 2018-2026
FIG 6. PROSTAGLANDIN MARKET, PORTERS 5 FORCE MODEL
FIG 7. PROSTAGLANDIN MARKET, PEST ANALYSIS
FIG 8. PROSTAGLANDIN MARKET, VALUE CHAIN ANALYSIS
FIG 9. PROSTAGLANDIN MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)
FIG 10. PROSTAGLANDIN MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)
FIG 11. PROSTAGLANDIN MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)
FIG 12. PROSTAGLANDIN MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)
FIG 13. PROSTAGLANDIN MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)
FIG 14. PROSTAGLANDIN MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)
FIG 15. PROSTAGLANDIN MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)
FIG 16. PROSTAGLANDIN MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)
FIG 17. PROSTAGLANDIN MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)
FIG 18. PROSTAGLANDIN MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)
FIG 19. PROSTAGLANDIN MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)
FIG 20. PROSTAGLANDIN MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)
FIG 21. PROSTAGLANDIN MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)
FIG 22. PROSTAGLANDIN MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)
FIG 23. PROSTAGLANDIN MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)
FIG 24. PROSTAGLANDIN MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)
FIG 25. PROSTAGLANDIN MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)
FIG 26. PROSTAGLANDIN MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)
FIG 27. PROSTAGLANDIN MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)
FIG 28. PROSTAGLANDIN MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)
FIG 29. PROSTAGLANDIN MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)
FIG 30. PROSTAGLANDIN MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)
FIG 31. PROSTAGLANDIN MARKET, REGIONAL SNAPSHOT 2016 & 2026
FIG 32. NORTH AMERICA PROSTAGLANDIN MARKET 2016 & 2026 (USD MILLION)
FIG 33. EUROPE PROSTAGLANDIN MARKET 2016 & 2026 (USD MILLION)
FIG 34. ASIA PACIFIC PROSTAGLANDIN MARKET 2016 & 2026 (USD MILLION)
FIG 35. LATIN AMERICA PROSTAGLANDIN MARKET 2016 & 2026 (USD MILLION)
FIG 36. PROSTAGLANDIN MARKET, COMPANY MARKET SHARE ANALYSIS (2017)
